tes-1 encodes an ortholog of human Testin. TES has been identified as a tumor suppressor(Tobias et al., 2001) and a novel focal adhesion-associated protein that can co-localize with paxillin and zyxin, which it depends on for focal adhesion targeting in mouse fibroblast cells(Garvalov et al., 2003). In addition, TES has been shown to enhance cell spreading and inhibit cell migration, highlighting its potential role as a tumor suppressor. Recently, TES was shown to co-localize with -catenin at sites of cell-cell contact in fibroblasts(Griffith et al., 2004), corroborating its potential role as a modulator of cell attachments.
tes-1 was identified in a screen for enhancers of embryonic lethality observed in worms homozygous for a hypomorphic allele (
fe4) of
hmp-1/-catenin. The
fe4 mutation results in ~70% embryonic lethality, with most embryos showing elongation defects and varying degrees of defects in circumferential F-actin bundles (CFBs). The knockdown of
tes-1 by feeding RNAi in
fe4 worms results in >98% embryonic lethality with the vast majority of embryos exhibiting the Humpback phenotype characterized by dorsal humps along the body axis. Using a TES-1::GFP fusion protein driven by the
tes-1 promoter, we have found that
tes-1 is expressed in the hypodermis and in neurons during embryogenesis. During the process of embryonic elongation, TES-1 expressed in seam hypodermal cells localizes with HMR-1 at sites of cell-cell contact, just apical to the DLG-1/AJM-1 complex. In adult hermaphrodites, TES-1 is expressed in many neurons including the nerve ring, ventral nerve cord and tail ganglia. In addition, TES-1 is expressed in epithelial cells of the vulva and uterus. Worms homozygous for a
tes-1 null allele (
ok1036) do not exhibit increased embryonic lethality